市場調查報告書
商品編碼
1173208
拇趾外翻矯正系統全球市場規模,份額和行業趨勢分析報告,按產品(可穿戴設備,植入物和配件),最終用戶(醫院,門診中心,專科中心)區域展望和預測2022-2028Global Bunion Correction Systems Market Size, Share & Industry Trends Analysis Report By Product (Wearables and Implants & Accessories), By End-Use (Hospitals, Ambulatory Centers, and Specialty Centers), By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,拇外翻矯正系統的全球市場規模預計將達到 11 億美元,預測期內復合年增長率為 7.1%。
美國踝關節骨科協會估計,大約三分之一的女性患有拇囊炎。 預計關節炎患者的增加將在預測期內對市場增長產生積極影響。 據說在類風濕性關節炎等炎症性關節炎的情況下更容易發生拇外翻。
患有類風濕性關節炎的人更容易出現足部問題。 根據 Vittori 的文章,腳部問題影響了全世界 90% 的類風濕性關節炎患者。 在類風濕性關節炎的情況下,據說拇囊炎更可能是由於身體錯誤地攻擊了拇囊炎的內層。 此外,這兩種疾病都有腫脹、關節活動不暢等症狀,市場有望擴大。
COVID-19 影響分析
由於擇期手術取消和尋求拇囊炎治療的人數減少,COVID-19 疫情對市場產生了負面影響。 市場還受到醫護人員短缺和政府為遏制病毒傳播而實施的旅行限制的不利影響。 大多數醫院和門診康復中心的入住率較低,進一步阻礙了市場擴張。 許多醫院正在縮減或推遲非緊急護理。 這不僅對醫院,而且對他們所服務的患者都有財務和醫療影響。 由於 COVID-19,護士和其他醫療保健專業人員不得不輪班工作更長時間,工作時間甚至更長。
市場增長因素
提高滲透率
隨著拇囊炎患者數量的增加,北美、亞太地區、歐洲和 LAMEA (MEA) 等地區對拇囊炎治療設備的需求也在增加。 這與從青少年到成人的所有年齡組的拇囊炎發病率增加有關。
提高認識
拇外翻矯正器的知名度在提高,使用頻率和手術次數也在增加。 拇囊炎也可能由其他疾病引起,例如關節炎、糖尿病和懷孕。 它們通常是由穿緊身鞋或過高的高跟鞋引起的。 今天,無論拇囊炎的原因是什麼,都有許多治療方法可以幫助您再次穿鞋感覺良好。 如果你想照顧好你的腳,拇囊炎需要仔細治療。
市場抑制因素
患者對拇外翻的認識不足
拇囊炎的第一個徵兆是在大腳趾關節的頂部或側面出現一個小的骨質凸起。 拇囊炎一開始通常不會痛,所以很多人都會忽視它,直到它開始變得比不舒服或疼痛更煩人。
產品概覽
拇外翻矯正系統市場按產品細分為可穿戴設備和植入配件。 到 2021 年,可穿戴設備將在所有產品類別中佔據最高的收入份額。 拇囊炎發病率上升是推動市場增長的關鍵影響因素之一。 根據殘疾人人口統計,大約36%的樣本人口有這種情況。
結束使用 Outlook
按最終用戶劃分,市場分為醫院、門診中心和專科中心。 醫院中矯正拇外翻的各種外科手術(如外切除術、截骨術和關節固定術)的可用性預計會增加接受這種病症治療的患者數量。 此外,由於醫院擁有優秀的醫生,該行業的增長也有望加速。
區域展望
按地區分析北美、歐洲、亞太地區和 LAMEA 的拇外翻矯正系統市場。 2021年,北美以全球市場份額最高的優勢主導了全球拇外翻矯正系統市場。 影響北美市場增長的關鍵因素包括該地區疾病的高發病率和矯正手術治療中心的可及性。
The Global Bunion Correction Systems Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 7.1% CAGR during the forecast period.
Products for bunion correction assist in the treatment of foot deformity, which affects the metatarsophalangeal joint. One in three Americans has bunion or hallux valgus, which is a prevalent foot ailment in the adult population. The condition is most frequently brought on by wearing uncomfortable, narrow shoes for a long period, foot injuries, and genetic foot issues.
According to a study by NCBI ( National Center for Biotechnology Information), between 63% and 74% of the participants wore shoes that were either too short or too wide, increasing their chance of developing foot conditions such as bunions, calluses, and deformities. Due to weaker connective fibers and the usage of tight, heeled shoes, the ailment is more prevalent in older people, particularly women.
The American Orthopedic Foot and Ankle Society estimates that roughly one-third of women have bunions. During the forecast period, increasing arthritis prevalence is anticipated to favorably impact market growth. Bunions are more likely to develop in cases of inflammatory arthritis, such as rheumatoid arthritis.
There is a higher chance that people with rheumatoid arthritis will experience foot issues. According to a Vittori article, foot problems affect 90% of rheumatoid arthritis sufferers worldwide. The likelihood of developing a bunion increase as a result of the body incorrectly attacking the big toe linings in rheumatoid arthritis. Additionally, both illnesses' symptoms include swelling and problems with joint movement, which are predicted to boost market growth.
COVID-19 Impact Analysis
Owing to the cancellation of elective surgeries and the decline in individuals seeking bunion therapy, the COVID-19 pandemic had an adverse effect on the market. The market was also negatively impacted by the lack of healthcare workers and the government-imposed travel restrictions made to stop the virus's spread. The majority of hospitals and outpatient rehabilitation centers operated at decreased capacity, which further hampered market expansion. Numerous hospitals have reduced or delayed non-emergency care. This has both financial and medical repercussions for the hospitals as well as the patients they serve. Nurses and other healthcare professionals had to work longer shifts and even more days as a result of COVID-19.
Market Growth Factors
Growing Prevalence
The demand for these devices has increased throughout several regions, including North America, Asia Pacific, Europe, and LAMEA, as a result of the rise in the number of people with bunions (MEA). This can be linked to the rising incidence of this condition among people of all ages, including teenagers and adults.
Increasing Awareness
Patients are becoming more aware of bunion correction devices, and they are using them more frequently and in more surgical procedures. Bunions can also be brought on by other disorders like arthritis, diabetes, or even pregnancy. They are frequently brought on by wearing tight shoes or overly high heels. There are numerous treatments available today that will help you feel wonderful in your shoes again, no matter what the root of your bunions may be. If it comes to foot care, bunions need to be treated carefully.
Market Restraining Factors
Patient's Ignorance towards the Condition
A little bony protrusion on the top or side of your big toe joint is the first sign of the bunion toe disease (also known as a bunionette when it affects the pinky toe) (or on the pinky toe for bunionettes). Because bunions are typically not painful at first, so many individuals ignore it till the discomfort and pain start to get more bothersome.
Product Outlook
Based on product, the Bunion Correction system market is segmented into Wearables and Implants & Accessories. The wearables segment garnered the highest revenue share among all product categories in 2021. The increasing occurrence of bunions is one of the key influencing factors fuelling the market growth. According to statistics from Disabled Population, approximately 36% of the sample population had the condition.
End-Use Outlook
By end-use, the market is segmented into Hospitals, Ambulatory Centers, and Specialty Centers. The number of patients receiving treatment for the issue at the hospitals is anticipated to increase as a result of factors like the accessibility of different surgical alternatives including Exostectomy, Osteotomy, and Arthrodesis for bunion correction. Additionally, it is anticipated that the hospitals' access to qualified doctors will accelerate category growth.
Regional Outlook
Region-wise, the Bunion Correction Systems Market is analyzed across North America, Europe, Asia Pacific, and LAMEA. In 2021, North America dominated the global Bunion Correction Systems market with the highest market share worldwide. Some of the major factors that influenced the market growth in the North America market include the higher incidence of the condition there as well as the accessibility of treatment centers for corrective operations.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Stryker Corporation, Arthrex, Inc., Zimmer Biomet Holdings, Inc., Extremity Medical, LLC., Acumed, LLC., De Puy Synthes (Johnson & Johnson), BioPro, Inc., and Orthofix Medical, Inc.
Strategies Deployed in Bunion Correction Systems Market
Jul-2022: Acumed acquired Exosmed, a medical device company specialized in providing innovative solutions to orthopedic surgeons. The acquisition enables Acumed to better serve minimally invasive surgical device customers globally.
Mar-2022: Orthofix received the approval from U.S. Food and Drug Administration 510(k) for TrueLok EVO Ring Fixation System. TrueLok EVO Ring Fixation System is designed for deformity correction procedures and complex limb reconstruction. This is the only circular fixator that has struts and radiolucent rings for clear radiographic visualization.
Feb-2022: Stryker acquired Vocera Communications, a provider of the leading platform for clinical workflow and communications. The acquisition enriched Stryker's Medical division through adding an innovative and complementary portfolio. The addition broadened the company's Advance Digital Healthcare offerings and advanced its focus on preventing unfavorable events during the continuum of care.
Feb-2022: DePuy Synthes took over CrossRoads Extremity Systems, a medical device company engaged in providing a wide range of procedure-focused, sterile-packed implants and instrumentation systems. This acquisition adds CrossRoads' products to DePuy's product portfolio reinforcing DePuy's portfolio of foot and ankle procedures.
Dec-2021: DePuy Synthes, a subsidiary of Johnson & Johnson acquired OrthoSpin, Ltd., a medical equipment manufacturing firm specializing in developing robotic treatment systems. With this acquisition, OrthoSpin helped DePuy in bringing transformative Medtech advancements to the industry through utilizing automated technology, which addresses a range of orthopaedic challenges.
Sep-2021: Stryker completed the acquisition of Gauss Surgical, a medical device company that developed an artificial intelligence-enabled platform, Triton. This platform was developed for real-time monitoring of blood loss at the time of surgery. Following this acquisition, Stryer aimed to utilize this platform for improving outcomes and safety for their patients and caregivers.
Jan-2021: Stryker took over OrthoSensor, a company focused on the digital evolution of sensor technology and musculoskeletal care for total joint replacement. Through this acquisition, the latter company empowered the former company's surgeons with exhaustive data-driven solutions. Additionally, Orhtosensor's portfolio reinforced Stryker's digital ecosystem foundation.
Dec-2020: Zimmer Biomet announced the acquisition of A&E Medical Corporation, a manufacturer of medical devices. The acquisition enabled Zimmer to deliver a comprehensive portfolio of sternal closure products, comprising rigid fixation. Rigid Fixation has the ability to address a range of unfulfilled surgical and patient requirements.
Mar-2020: Orthofix announced the acquisition of FITBONE, a brand of Wittenstein SE. FITBONE is an intramedullary lengthening system for limb lengthening of the tibia and femur. With this acquisition, FITBONE enhanced Orthofix's limb reconstruction portfolio allowing physicians to better serve the needs of patients that require internal and external fixation procedures.
Market Segments covered in the Report:
By Product
By End Use
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures